×

img Accessibility Controls

Technologies Banner

All Technologies

Process Development of Drugs Repurposed for COVID-19

Implementing Organization

National Institute for Interdisciplinary Science and Technology (NIIST)
CSIR-North East Institute of Science & Technology, Assam

Project Overview

Process developed for Nitazoxanide, EIDD 1931 & EIDD 2801. Non-infringing routes developed for the APIs. Nitazoxanide is currently under clinical trials in Mexico. EIDD 2801 is currently under clinical trials in USA & UK.
Quick Information
Thrust Areas
Chemical Sciences
Focus Area
Development of Repurposed Drugs for COVID-19
Output
TRL: Technology Readiness Level
Technology development
Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
arrowtop
Latest Updates
Loading…